MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED
MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED having CIN U85300ML2022SGC013895 is 2 years , 7 month & 11 days old Public Indian Company incorporated on 13 Nov 2022. It is classified as State government company and is registered at ROC Shillong. Its authorized share capital is Rs. 1,500,000 and its paid up capital is Rs. 500,000. It's NIC code is 85300 (which is part of its CIN).
As per the NIC code, it is involved in . MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-29-2023. Directors of MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED are Joram Beda and Lumlang Thangkhiew.
MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED ' Corporate Identification Number (CIN) is U85300ML2022SGC013895 and its registration number is 013895. Users may contact MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED on its Email address - joelyngdohnhm@gmail.com Registered address of MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED is OFFICE OF THE MISSION DIRECTOR,NHM DHS, LAITUMKHRAH , NEW COLONY,SHILLONG,Meghalaya,India-793003. Current status of MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED is - Active.
Key Indicators
as on 24/06/2025
as on 24/06/2025
Company Information
| CIN | U85300ML2022SGC013895 |
|---|---|
| Company Status | Active |
| Registration Number | 013895 |
| Date of Incorporation | 11/13/2022 |
| RoC | ROC Shillong |
| Company Age | 2 years & 224 days |
| Authorized Capital | ₹ 1500000 |
| Paid-up capital | ₹ 500000 |
| Company Category | Company limited by shares |
| Company Sub-Category | State government company |
| Class of company | Public |
| Activity | |
| Listing status | Unlisted |
| Date of Last Annual General Meeting | 31-03-2023 |
| Date of Latest Balance Sheet |
Contact
| Email ID | joelyngdohnhm@gmail.com |
|---|---|
| Address | OFFICE OF THE MISSION DIRECTOR,NHM DHS, LAITUMKHRAH , NEW COLONY SHILLONG Meghalaya India 793003 |
| Website | ********.com |
| Contact Number | +91******* |
Location on Map
Director
| DIN | Name | Date OF Appointment | Designation | Tenure |
|---|---|---|---|---|
| 08131234 | 03 Mar 2023 | Director | 2 years | |
| 09789363 | 13 Nov 2022 | Director | 2 years | |
| 09789364 | 13 Nov 2022 | Director | 2 years | |
| 09789365 | 13 Nov 2022 | Director | 2 years | |
| 10650872 | 31 May 2024 | Director | 2 years | |
| 10566463 | 28 Mar 2024 | Director | 2 years | |
| 10566459 | 28 Mar 2024 | Director | 2 years | |
| 10332559 | 23 Sep 2023 | Director | 2 years | |
| 10332561 | 23 Sep 2023 | Director | 2 years | |
| 10316351 | 13 Sep 2023 | Director | 2 years |
Companies connected through Directors
| Name | Status | Paid Up Capital | Common Directors | Address |
|---|---|---|---|---|
| 5,15,00,000.00 | 1 | Meghalaya | ||
| 5,06,000.00 | 2 | Meghalaya | ||
| 1,00,00,000.00 | 2 | Meghalaya |
Charges on assets
| Charge Holder | Branch | Amount | Date of creation | Modification | Satisfaction | Status |
|---|---|---|---|---|---|---|
| Not Available | ||||||
Registered Details
* There is the date provided by MCA, but availability for this year is not guaranteed.
Key Metrics
** All rupee values in INR crores. Based on March 2024 numbers.
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
9.29%
0.00%
Financial Highlights
** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales |
|
|
|
|
|
| Operating profit |
|
|
|
|
|
| Net profit |
|
|
|
|
|
| Gross margin |
|
|
|
|
|
| Operating margin |
|
|
|
|
|
| Net margin |
|
|
|
|
|
| Networth |
|
|
|
|
|
| Borrowings |
|
|
|
|
|
| Assets |
|
|
|
|
|
| Debt to equity |
|
|
|
|
|
| Current ratio |
|
|
|
|
|
| ROE |
|
|
|
|
|
| Days payable |
|
|
|
|
|
| WC days |
|
|
|
|
|
Balance Sheet
**** All numbers in INR
|
Mar 2020
|
Mar 2021
|
Mar 2022
|
Mar 2023
|
Mar 2024
|
|
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| (1) Shareholders‘ funds | |
|
|
|
|
| (a) Share capita | |
|
|
|
|
| (b) Reserves and surplus | |
|
|
|
|
| (c) Money received against share warrants | |
|
|
|
|
| (2) Share application money pending allotment | |
|
|
|
|
| (3) Non-current liabilities | |
|
|
|
|
| (a) Long-term borrowings | |
|
|
|
|
| (b) Deferred tax liabilities (Net) | |
|
|
|
|
| (c) Other Long-term liabilities | |
|
|
|
|
| (d) Long-term provisions | |
|
|
|
|
| (4) Current liabilities | |
|
|
|
|
| (a) Short-term borrowings | |
|
|
|
|
| (b) Trade payables | |
|
|
|
|
| (A) total outstanding dues of micro enterprises and small enterprises; and | |
|
|
|
|
| (B) total outstanding dues of creditors other than micro enterprises and small enterprises. | |
|
|
|
|
| (c) Other current liabilities | |
|
|
|
|
| (d) Short-term provisions | |
|
|
|
|
| Total | |
|
|
|
|
| ASSETS | |||||
| Non-current assets | |
|
|
|
|
| (a) [Property, Plant and Equipment] | |
|
|
|
|
| (i) Tangible assets | |
|
|
|
|
| (ii) Intangible assets | |
|
|
|
|
| (iii)Capital work-in-progress | |
|
|
|
|
| (iv) Intangible assets under development | |
|
|
|
|
| (b) Non-current investments | |
|
|
|
|
| (c) Deferred tax assets (net) | |
|
|
|
|
| (d) Long-term loans and advances | |
|
|
|
|
| (e) Other non-current assets | |
|
|
|
|
| (2) Current assets | |
|
|
|
|
| (a) Current investments | |
|
|
|
|
| (b) Inventories | |
|
|
|
|
| (c) Trade receivables | |
|
|
|
|
| (d) Cash and cash equivalents | |
|
|
|
|
| (e) Short-term loans and advances | |
|
|
|
|
| (f) Other current assets | |
|
|
|
|
| Total assets | |
|
|
|
|
| EQUITY AND LIABILITIES | ||||
| (1) Shareholders‘ funds | ||||
| (a) Share capital | ||||
| (b) Reserves and surplus | ||||
| (c) Money received against share warrants | ||||
| (2) Share application money pending allotment | ||||
| (3) Non-current liabilities | ||||
| (a) Long-term borrowings | ||||
| (b) Deferred tax liabilities (Net) | ||||
| (c) Other Long-term liabilities | ||||
| (d) Long-term provisions | ||||
| (4) Current liabilities | ||||
| (a) Short-term borrowings | ||||
| (b) Trade payables | ||||
| (A) total outstanding dues of micro enterprises and small enterprises; and | ||||
| (B) total outstanding dues of creditors other than micro enterprises and small enterprises. | ||||
| (c) Other current liabilities | ||||
| (d) Short-term provisions | ||||
| Total | ||||
| ASSETS | ||||
| Non-current assets | ||||
| (a) [Property, Plant and Equipment] | ||||
| (i) Tangible assets | ||||
| (ii) Intangible assets | ||||
| (iii)Capital work-in-progress | ||||
| (iv) Intangible assets under development | ||||
| (b) Non-current investments | ||||
| (c) Deferred tax assets (net) | ||||
| (d) Long-term loans and advances | ||||
| (e) Other non-current assets | ||||
| (2) Current assets | ||||
| (a) Current investments | ||||
| (b) Inventories | ||||
| (c) Trade receivables | ||||
| (d) Cash and cash equivalents | ||||
| (e) Short-term loans and advances | ||||
| (f) Other current assets | ||||
| Total assets | ||||
Profit & Loss
**** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| I.Revenue from operations | |
|
|
|
|
| II. Other income | |
|
|
|
|
| III.Total Revenue (I + II) | |
|
|
|
|
| IV.Expenses | |
|
|
|
|
| (1)Cost of materials consumed | |
|
|
|
|
| (2)Purchases of Stock-in-Trade | |
|
|
|
|
| (3)Changes in inventories of finished goods work-in-progress and | |
|
|
|
|
| (4)Stock-in-Trade | |
|
|
|
|
| (5)Employee benefits expense | |
|
|
|
|
| (6)Finance costs | |
|
|
|
|
| (7)Depreciation and amortisation expense | |
|
|
|
|
| (8)Other expenses | |
|
|
|
|
| (9)Total expenses | |
|
|
|
|
| VProfit before exceptional and extraordinary items and tax (III - IV) | |
|
|
|
|
| VIExceptional items | |
|
|
|
|
| VII.Profit before extraordinary items and tax (V - VI) | |
|
|
|
|
| VIII.Extraordinary items | |
|
|
|
|
| IX.Profit before tax (VII- VIII) | |
|
|
|
|
| X. Tax expense: | |
|
|
|
|
| (1)Current tax | |
|
|
|
|
| (2)Deferred tax | |
|
|
|
|
| XI.Profit (Loss) for the period from continuing operations (VII-VIII) | |
|
|
|
|
| XII.Profit/(loss) from discontinuing operations | |
|
|
|
|
| XIII.Tax expense of discontinuing operations | |
|
|
|
|
| XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) | |
|
|
|
|
| XV.Profit (Loss) for the period (XI + XIV) | |
|
|
|
|
| XVI.Earnings per equity share: | |
|
|
|
|
| (1) Basic | |
|
|
|
|
| (2)Diluted | |
|
|
|
|
| Precentage of total incomex |
|---|
Ratio
** All numbers in INR
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt/Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Liquidity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quick Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Performance | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Margin | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-tax ROCE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pre-tax ROIC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Inventory | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Receivable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Subsidiaries, Associate Companies & Join Ventures of Meghalayan Medical Drugs And Services Limited
| Company Identifier | Name | Percentage of Shares Held |
|---|---|---|
|
|
|
|
|
|
|
|
|
Fund Raising Activity of Meghalayan Medical Drugs And Services Limited
| Date of Allotment | Securities Alloted | Terms | Number of Securities | Nominal Amount | Premium Amount Due & Payable | Premium Amount Paid | Total Discount | Amount to be Paid on Calls (Excluding Premium) | Attachments |
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board Meetings of Meghalayan Medical Drugs And Services Limited
| Date of Filing | Date of Dispatch of Notice | Section (Companies Act 2013) | Purpose of passing the resolution | Subject Matter of Resolution | Resolution Agreed By | Special Resolution | Address |
|---|
Auditors of Meghalayan Medical Drugs And Services Limited
| Financial Year | Name of Auditor or Firm | PAN of Auditor or Firm | Membership Number | Registration Number | Address |
|---|
Outstanding Payments to Micro & Small Enterprises
| Filing Type | As On | Amount Due to MSME | Current Liabilities | Ratio to Current Liabilities | Reasons for Delay |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investor Complaints & Serious Complaints About Meghalayan Medical Drugs And Services Limited
Director Complain
| Date | DIN | Cessation Date | Cessation Reason | Complaint |
|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Serious Complaints
| Date | Complaint | Other |
|---|---|---|
|
|
|
|
|
|
|
|
|
Investor Complaints & Other Complaints
| Date | Complaint Type | Complaint Sub Type | Particulars of Secutiries | Period | Complaint | Other Details |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Prosecution Details of Meghalayan Medical Drugs And Services Limited
| S.No. | Defaulting Entities | Court Name | Prosecution Section | Date of Order | Status |
|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FAQs- Meghalayan Medical Drugs And Services Limited
MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED having CIN U85300ML2022SGC013895 is 2 years , 7 month old Public Indian Company incorporated with MCA on 13 Sep 2023. MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED is listed in the class of Public Indian Company and classified as State government company. This company is registered at Registrar of Companies(ROC), ROC Shillong with an Authorized Share Capital of 1,500,000 and paid-up capital is 500,000.
CIN of MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED is U85300ML2022SGC013895.
Address of MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED is Office of the mission director,nhm dhs, laitumkhrah , new colony,shillong,meghalaya,india-793003,.
The company has 11 directors/key management personnel Sampath Kumar,joram Beda,rosetta Kurbah,ramkumar Sathurappan,sampath Pamu,janupribalas Momin,wolker Kharlukhi,fairnolyn Kharshiing,rilynti Lyngdoh,rafellia Allya,lumlang Thangkhiew,
Email : joelyngdohnhm@gmail.com
Address : OFFICE OF THE MISSION DIRECTOR,NHM DHS, LAITUMKHRAH , NEW COLONY SHILLONG Meghalaya India 793003
MEGHALAYAN MEDICAL DRUGS AND SERVICES LIMITED is involved in activities such as Computer programming, consultancy and related activities
Popular Services
Popular Search
Top Companies in your State
- ANANGESHWAR PARWATI RAMANUGRAH PROJECTS PRIVATE LIMITED
- BEAVER TECHNOCRATE PRIVATE LIMITED
- BUSINESS LINE (ISPAT) PRIVATE LIMITED
- HARIOM ROHAN CONSTRUCTION PRIVATE LIMITED
- HIMALIYA DEVELOPERS INDIA PRIVATE LIMITED
- INDRA RANI CONSTRCTION AND SUPPLIERS PRIVATE LIMITED
- MAA SINHASINI INFRASTRUCTURE PRIVATE LIMITED
- MOTIVE BROKING & ADVISORY PRIVATE LIMITED
- NIRSHILP COMMODITIES AND TRADING PRIVATE LIMITED
- OMNIBUS INDUSTRIAL DEVELOPMENT CORPORATION OF DAMAN DIU AND DADRA NAGAR HAVELI LIMITED
- PRIMECOUNSEL PRIVATE LIMITED
- QCAP SECURITIES PRIVATE LIMITED
- SHAAFIA FOREX PRIVATE LIMITED
- SMIT (DAMAN) ESTATES PRIVATE LIMITED
- ALBEMARLE CHEMICALS PRIVATE LIMITED
- BEYOND BORDERS TRAVEL MANAGEMENT CO PRIVATE LIMITED
- COEUS EDUCATION MANAGEMENT PRIVATE LIMITED
- COFCO INTERNATIONAL INDIA PRIVATE LIMITED
- EVOTEK HYDRAULIC TECHNOLOGY INDIA PRIVATE LIMITED
- EXXONMOBIL COMPANY INDIA PRIVATE LIMITED
- HALITE PERSONAL CARE INDIA PRIVATE LIMITED
Exclusive Access 